Drug Profile
Gallium 68 P15 041
Alternative Names: [68Ga]P15-041Latest Information Update: 25 Jan 2023
Price :
$50
*
At a glance
- Originator Five Eleven Pharma
- Class Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase 0 Bone metastases
Most Recent Events
- 25 Jan 2023 Gallium 68 P15 041 is still in phase-0 trials for Bone metastases (Diagnosis) in USA (Parenteral) (NCT02826382)
- 31 Dec 2022 Five Eleven Pharma completes a phase-0 trial in Bone metastases (Diagnosis) in USA (Parenteral) (NCT02826382)
- 28 Aug 2019 No recent reports of development identified for phase-0 development in Bone metastases(Diagnosis) in USA (Parenteral)